CochLear Debt to Equity Ratio 2023-2024 | CHEOY

Current and historical debt to equity ratio values for CochLear (CHEOY) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. CochLear debt/equity for the three months ending December 31, 2024 was 0.00.
CochLear Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2024-12-31 $0.60B $1.22B 0.49
2024-06-30 $0.59B $1.21B 0.49
2023-12-31 $0.49B $1.16B 0.42
2023-06-30 $0.55B $1.18B 0.47
2022-06-30 $0.57B $1.22B 0.46
Sector Industry Market Cap Revenue
Medical Medical Services $12.835B $1.488B
Cochlear Limited provides implantable hearing solutions principally in the Americas, Europe, the Middle East, Africa and the Asia Pacific. The company offers cochlear implants, including Nucleus 7 and Kanso sound processors; Carina middle-ear implants and accessories and Baha bone conduction implants. Cochlear Limited is based in Sydney, Australia.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $138.339B 25.95
CVS Health (CVS) United States $80.708B 10.03
Elevance Health (ELV) United States $77.846B 10.05
Cencora (COR) United States $57.726B 20.08
DiDi Global (DIDIY) China $28.851B 30.65
Labcorp Holdings (LH) United States $20.589B 16.70
Natera (NTRA) United States $20.264B 0.00
BioMerieux (BMXMF) France $16.861B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $13.895B 0.00
Solventum (SOLV) United States $12.635B 13.38
ICON (ICLR) Ireland $11.632B 10.81
Revvity (RVTY) United States $11.186B 19.25
Viatris (VTRS) United States $10.657B 3.66
Medpace Holdings (MEDP) United States $9.049B 24.03
Sonic Healthcare (SKHHY) Australia $8.827B 0.00
Avantor (AVTR) United States $8.763B 12.73
HealthEquity (HQY) United States $8.446B 37.00
Caris Life Sciences,�Inc (CAI) United States $7.988B 0.00
Charles River Laboratories (CRL) United States $7.610B 14.91
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $4.943B 29.10
BrightSpring Health Services (BTSG) United States $3.527B 32.35
Sotera Health (SHC) United States $3.188B 18.11
Surgery Partners (SGRY) United States $2.902B 37.73
Alignment Healthcare (ALHC) United States $2.649B 0.00
Concentras Parent (CON) United States $2.522B 14.58
Organon (OGN) United States $2.503B 2.66
GeneDx Holdings (WGS) United States $2.296B 88.43
Progyny (PGNY) United States $1.973B 43.43
PACS (PACS) United States $1.882B 0.00
Premier (PINC) United States $1.730B 13.13
Ardent Health (ARDT) United States $1.718B 7.32
GoodRx Holdings (GDRX) United States $1.700B 34.00
Teladoc Health (TDOC) United States $1.382B 0.00
Establishment Labs Holdings (ESTA) $1.263B 0.00
Pediatrix Medical (MD) United States $1.101B 8.38
CareDx (CDNA) United States $1.069B 16.70
Ryman Healthcare (RYHTY) New Zealand $0.970B 0.00
Agilon Health (AGL) United States $0.894B 0.00
QDM (QDMI) Hong Kong, SAR China $0.848B 291.00
AMN Healthcare Services Inc (AMN) United States $0.754B 7.06
InnovAge Holding (INNV) United States $0.590B 0.00
Nutex Health (NUTX) United States $0.578B 8.75
Embecta (EMBC) United States $0.570B 3.84
SBC Medicals (SBC) United States $0.543B 0.00
So-Young (SY) China $0.530B 0.00
LifeMD (LFMD) United States $0.514B 0.00
Omada Health (OMDA) $0.476B 0.00
Auna S.A (AUNA) Luxembourg $0.474B 10.67
Sonida Senior Living (SNDA) United States $0.473B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.368B 0.00
Enhabit (EHAB) United States $0.346B 28.50
Performant Healthcare (PHLT) United States $0.318B 0.00
Oncology Institute (TOI) United States $0.288B 0.00
Beauty Health (SKIN) United States $0.217B 0.00
DocGo (DCGO) United States $0.145B 23.67
Pheton Holdings (PTHL) China $0.138B 0.00
Sera Prognostics (SERA) United States $0.112B 0.00
Ascend Wellness Holdings (AAWH) United States $0.074B 0.00
KindlyMD (NAKA) United States $0.069B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
IceCure Medical (ICCM) Israel $0.060B 0.00
Basel Medical Group (BMGL) Singapore $0.050B 0.00
Biodesix (BDSX) United States $0.045B 0.00
ModivCare (MODV) United States $0.042B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.036B 0.00
OSR Holdings (OSRH) United States $0.020B 0.00
Intelligent Bio Solutions (INBS) United States $0.015B 0.00
Co-Diagnostics (CODX) United States $0.009B 0.00
BioNexus Gene Lab (BGLC) $0.008B 0.00
SeaStar Medical Holding (ICU) United States $0.007B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00